Michèle Ollier, MD and Business Master (Paris, France) joined the Index Ventures life science team as a Partner in 2006. From 2003, she was Director of Investment in Life Sciences at Edmond de Rothschild Investment Partners in Paris. During the previous 15 years she has acquired extensive pharmaceutical and biotechnology experience with companies such as Sanofi Pharma International, Bristol Myers Squibb France, Rhone Poulenc Rorer International/RPR Gencell in the capacities of strategy, development and commercialisation of pharmaceutical products as well as at Serono International. Michele sits on the board of a number of Index Venture Life Science portfolio companies including Cyrenaic, NormOxys, Sonkei, Aegerion, LinguaFlex and she is the chairman FunXional Therapeutics. Michèle’s knowledge base spans numerous therapeutic areas including neurology, cardiology, oncology and reproductive medicine.